UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 164

Sortiert nach

SOX2‐mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma

International journal of cancer, 2018-12, Vol.143 (12), p.3131-3142

2018

Volltextzugriff (PDF)

Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target

International journal of cancer, 2019-12, Vol.145 (12), p.3462-3477

2019

Volltextzugriff (PDF)

Diffuse infiltrating tumour with the molecular profile of an atypical teratoid rhabdoid tumour (AT/RT SHH‐1B) in an adult patient

Neuropathology and applied neurobiology, 2024-06, Vol.50 (3), p.e12983-n/a

2024

Volltextzugriff (PDF)

FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor

International journal of cancer, 2021-08, Vol.149 (3), p.657-674

2021

Volltextzugriff (PDF)

T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cells

British journal of cancer, 2020-03, Vol.122 (7), p.1023-1036

2020

Volltextzugriff (PDF)

Low‐grade diffusely infiltrative tumour (LGDIT), SMARCB1‐mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT‐MYC

Neuropathology and applied neurobiology, 2022-06, Vol.48 (4), p.e12797-n/a

2022

Volltextzugriff (PDF)

Patient‐ and xenograft‐derived organoids recapitulate pediatric brain tumor features and patient treatments

EMBO molecular medicine, 2023-12, Vol.15 (12), p.e18199-n/a

2023

Volltextzugriff (PDF)

Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses

Acta neuropathologica communications, 2023-01, Vol.11 (1), p.7-7, Article 7

2023

Volltextzugriff (PDF)

Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma

Molecular therapy. Oncolytics, 2020-09, Vol.18, p.83-99

2020

Volltextzugriff (PDF)

Secretogranin II influences the assembly and function of MHC class I in melanoma

Experimental hematology & oncology, 2023-03, Vol.12 (1), p.29-29, Article 29

2023

Volltextzugriff (PDF)

Abstract 431: FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.431-431

2023

Volltextzugriff (PDF)

HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in Melanoma

Cancers, 2020-12, Vol.12 (12), p.3761

2020

Volltextzugriff (PDF)

Design and Evaluation of a 2Mbps SEC Transceiver for Automotive Networks

IEEE transactions on circuits and systems. II, Express briefs, 2024-06, Vol.71 (6), p.3021-3025

2024

Volltextzugriff (PDF)

2-Mbps Power-Line Communication Transmitter Based on Switched Capacitors for Automotive Networks

Electronics (Basel), 2022-11, Vol.11 (22), p.3651

2022

Volltextzugriff (PDF)

OTME-3. Dissection of the role of stromal microenvironment and tumor-TME crosstalk in pediatric brain cancer

Neuro-oncology advances, 2021-07, Vol.3 (Supplement_2), p.ii13-ii14

2021

Volltextzugriff (PDF)

ETMR-23. CNS SARCOMAS WITHCIC- ORATXN1-ALTERATIONS — A META-ANALYSIS OF CLINICAL AND MOLECULAR FEATURES IN A LARGE SERIES OF PATIENTS

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Suppl 4), p.0-0

2024

Volltextzugriff (PDF)

EPEN-18. MULTI-OMICS APPROACH REVEALED A TIGHT BLOOD-BRAIN BARRIER IN EPENDYMOMA

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Suppl 4), p.0-0

2024

Volltextzugriff (PDF)

Abstract A180: The histone methyltransferase SETDB1 contributes to melanoma tumorigenesis

Molecular cancer therapeutics, 2018-01, Vol.17 (1_Supplement), p.A180-A180

2018

Volltextzugriff (PDF)

MEDB-52. Organoids as preclinical models to improve and personalize disease outcome for sonic hedgehog medulloblastoma

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i118-i118

2022

Volltextzugriff (PDF)

Abstract 1274: Partial reprogramming of melanoma cells confers drug resistance and increased vulnerability to channel antagonists

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1274-1274

2019

Volltextzugriff (PDF)

CNSC-04. EXPLORATION OF INTERCELLULAR NETWORKS IN EPENDYMOMA REVEALS POTENTIAL THERAPEUTIC VULNERABILITIES

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Suppl 4), p.0-0

2024

Volltextzugriff (PDF)

EPEN-16. BULK AND SINGLE-CELL SPATIAL CHARACTERIZATION OF THE TUMOR IMMUNE MICROENVIRONMENT OF POSTERIOR FOSSA GROUP A EPENDYMOMAS

Neuro-oncology (Charlottesville, Va.), 2024-06, Vol.26 (Suppl 4), p.0-0

2024

Volltextzugriff (PDF)

Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities

Oncogene, 2023-05, Vol.42 (20), p.1661-1671

2023

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(147)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

SOX2‐mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma

Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target

Diffuse infiltrating tumour with the molecular profile of an atypical teratoid rhabdoid tumour (AT/RT SHH‐1B) in an adult patient

FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor

T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cells

ATRT–SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance

Low‐grade diffusely infiltrative tumour (LGDIT), SMARCB1‐mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT‐MYC

Patient‐ and xenograft‐derived organoids recapitulate pediatric brain tumor features and patient treatments

Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses

Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma

Secretogranin II influences the assembly and function of MHC class I in melanoma

Abstract 431: FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor

The Effect of Weaning with Adult Food Typical of the Mediterranean Diet on Taste Development and Eating Habits of Children: A Randomized Trial

HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in Melanoma

Design and Evaluation of a 2Mbps SEC Transceiver for Automotive Networks

2-Mbps Power-Line Communication Transmitter Based on Switched Capacitors for Automotive Networks

OTME-3. Dissection of the role of stromal microenvironment and tumor-TME crosstalk in pediatric brain cancer

ETMR-23. CNS SARCOMAS WITHCIC- ORATXN1-ALTERATIONS — A META-ANALYSIS OF CLINICAL AND MOLECULAR FEATURES IN A LARGE SERIES OF PATIENTS

EPEN-18. MULTI-OMICS APPROACH REVEALED A TIGHT BLOOD-BRAIN BARRIER IN EPENDYMOMA

Abstract A180: The histone methyltransferase SETDB1 contributes to melanoma tumorigenesis

MEDB-52. Organoids as preclinical models to improve and personalize disease outcome for sonic hedgehog medulloblastoma

Abstract 1274: Partial reprogramming of melanoma cells confers drug resistance and increased vulnerability to channel antagonists

CNSC-04. EXPLORATION OF INTERCELLULAR NETWORKS IN EPENDYMOMA REVEALS POTENTIAL THERAPEUTIC VULNERABILITIES

EPEN-16. BULK AND SINGLE-CELL SPATIAL CHARACTERIZATION OF THE TUMOR IMMUNE MICROENVIRONMENT OF POSTERIOR FOSSA GROUP A EPENDYMOMAS

Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities

Suchergebnisse filtern